Department of Psychology, Brigham Young University, Provo, UT, USA.
Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
J Parkinsons Dis. 2021;11(2):877-883. doi: 10.3233/JPD-202429.
Parkinson's disease (PD) is associated with sleep disturbance (SD) and sleep-related impairment (SRI). Validation of self-report measures of these problems is needed in PD. The Patient-Reported Outcomes Measurement Information System (PROMIS) includes tools that assess these problems (PROMIS-SD and PROMIS-SRI, respectively).
This study aimed to further validate these measures in individuals with PD and matched controls.
Individuals with early-stage PD (n=50) and matched controls (n=48) completed measures of SD including the PROMIS-SD, Pittsburgh Sleep Quality Index (PSQI), and Insomnia Severity Index (ISI). They also completed measures of daytime impairment including the PROMIS-SRI, Epworth Sleepiness Scale, State-Trait Anxiety Inventory, Beck Depression Inventory 2nd edition, and Parkinson's Disease Questionnaire-39. Internal consistency for the PROMIS measures were assessed using Cronbach's α coefficient and item-total correlations in the total sample. Convergent and divergent validity of the PROMIS item banks were assessed using Spearman correlations.
The PROMIS item banks had excellent internal consistency (α>0.94). Supporting convergent validity, the PROMIS-SD had strong correlations with other measures of SD (ρ>0.68, for PSQI and ISI) and the PROMIS-SRI had moderate to strong correlations with all measures of daytime impairment (ρ=0.41-0.72). Supporting divergent validity within the PD group, the PROMIS-SD correlated more strongly with SRI than with the Parkinson's Disease Questionnaire total score, a metric of PD related impairment.
In middle-aged and older adults, with and without early-stage PD, the PROMIS-SD and PROMIS-SRI are reliable and valid measures of SD and SRI, respectively.
帕金森病(PD)与睡眠障碍(SD)和与睡眠相关的损害(SRI)有关。在 PD 中需要验证这些问题的自我报告测量方法。患者报告的结果测量信息系统(PROMIS)包括分别评估这些问题的工具(PROMIS-SD 和 PROMIS-SRI)。
本研究旨在进一步验证这些在 PD 患者和匹配对照中测量工具的有效性。
50 名早期 PD 患者(n=50)和 48 名匹配对照(n=48)完成了 SD 测量,包括 PROMIS-SD、匹兹堡睡眠质量指数(PSQI)和失眠严重程度指数(ISI)。他们还完成了白天损害的测量,包括 PROMIS-SRI、Epworth 嗜睡量表、状态-特质焦虑量表、贝克抑郁量表第 2 版和帕金森病问卷 39。使用 Cronbach 的 α 系数和总样本中的项目-总分相关性评估 PROMIS 测量的内部一致性。使用 Spearman 相关系数评估 PROMIS 项目库的聚合和发散有效性。
PROMIS 项目库具有出色的内部一致性(α>0.94)。支持聚合有效性,PROMIS-SD 与其他 SD 测量(ρ>0.68,对于 PSQI 和 ISI)具有很强的相关性,而 PROMIS-SRI 与所有白天损害测量(ρ=0.41-0.72)具有中度至很强的相关性。在 PD 组内支持发散有效性,PROMIS-SD 与 SRI 的相关性强于与帕金森病问卷总分的相关性,帕金森病问卷总分是 PD 相关损害的度量。
在中年及以上年龄的成年人中,无论是否患有早期 PD,PROMIS-SD 和 PROMIS-SRI 都是 SD 和 SRI 的可靠且有效的测量工具。